The higher levels of CD49d expression and NF-κB activation in NOTCH1-mutated compared with NOTCH1-wild-type CLL are likely due to the higher NOTCH1 activation induced by mutations (7, 29, 107). This evidence concerns the gene NFKB1 and B-cell chronic lymphocytic leukemia.